{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:53:32Z","timestamp":1791849212416,"version":"4.3.4"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T00:00:00Z","timestamp":1602806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006279","name":"St. Jude Medical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006279","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.atherosclerosis.2020.10.014","type":"journal-article","created":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T03:17:06Z","timestamp":1602645426000},"page":"58-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":262,"special_numbering":"C","title":["Endothelial dysfunction in COVID-19: Current findings and therapeutic implications"],"prefix":"10.1016","volume":"314","author":[{"given":"Matthias P.","family":"N\u00e4gele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1766-8720","authenticated-orcid":false,"given":"Bernhard","family":"Haubner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix C.","family":"Tanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Ruschitzka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas J.","family":"Flammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib1","doi-asserted-by":"crossref","first-page":"382","DOI":"10.15585\/mmwr.mm6913e2","article-title":"COVID-response team: preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 - United States, february 12-march 28, 2020","volume":"69","author":"Cdc","year":"2020","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib2","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in wuhan, China","volume":"180","author":"Wu","year":"2020","journal-title":"JAMA Intern Med."},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib3","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib4","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jamacardio.2020.1017","article-title":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)","volume":"5","author":"Guo","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/00004872-200502000-00001","article-title":"Endothelial function and dysfunction. Part II: association with cardiovascular risk factors and diseases. a statement by the working group on endothelins and endothelial factors of the European society of hypertension","volume":"23","author":"Brunner","year":"2005","journal-title":"J. Hypertens."},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib6","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1161\/CIRCULATIONAHA.112.093245","article-title":"The assessment of endothelial function: from research into clinical practice","volume":"126","author":"Flammer","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/eurheartj\/ehx565","article-title":"Retinal microvascular dysfunction in heart failure","volume":"39","author":"N\u00e4gele","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib8","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.cell.2020.04.035","article-title":"SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues","volume":"181","author":"Ziegler","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib9","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00607-2020","article-title":"Pathogenesis of COVID-19 from a cell biology perspective","volume":"55","author":"Mason","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib10","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"8","author":"Yang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s13054-020-02872-z","article-title":"Acute kidney injury in SARS-CoV-2 infected patients","volume":"24","author":"Fanelli","year":"2020","journal-title":"Crit. Care"},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib12","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib13","first-page":"10","article-title":"Redox biology of respiratory viral infections","author":"Khomich","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib14","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1056\/NEJMc2009020","article-title":"ST-segment elevation in patients with covid-19 - a case series","volume":"382","author":"Bangalore","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib15","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.3557","article-title":"Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19)","author":"Puntmann","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib16","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.atherosclerosis.2020.06.008","article-title":"Management of acute myocardial injury in patients with confirmed or suspected COVID-19","volume":"305","author":"Chatzizisis","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib17","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.3551","article-title":"Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases","author":"Lindner","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib18","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ijcard.2016.09.008","article-title":"Endothelial function and sympathetic nervous system activity in patients with Takotsubo syndrome","volume":"224","author":"Naegele","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib19","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12872-015-0124-z","article-title":"Endothelial cell control of thrombosis","volume":"15","author":"Yau","year":"2015","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib20","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.jacc.2016.07.755","article-title":"Carbamylated low-density lipoproteins induce a prothrombotic state via LOX-1: impact on arterial thrombus formation in vivo","volume":"68","author":"Holy","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib21","doi-asserted-by":"crossref","first-page":"e575","DOI":"10.1016\/S2352-3026(20)30216-7","article-title":"Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study","volume":"7","author":"Goshua","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.thromres.2020.04.024","article-title":"Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy","volume":"191","author":"Lodigiani","year":"2020","journal-title":"Thromb. Res."},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib23","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1016\/j.jacc.2020.04.031","article-title":"COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review","volume":"75","author":"Bikdeli","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2020.10.014_bib24","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1002\/ctm2.44","article-title":"COVID-19 critical illness pathophysiology driven by diffuse pulmonary thrombi and pulmonary endothelial dysfunction responsive to thrombolysis","volume":"10","author":"Poor","year":"2020","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib25","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in covid-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib26","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1164\/rccm.202003-0817LE","article-title":"COVID-19 does not lead to a \"typical\" acute respiratory distress syndrome","volume":"201","author":"Gattinoni","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.19327","article-title":"SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases","author":"Colmenero","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib28","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1111\/bph.13517","article-title":"Targeting vascular (endothelial) dysfunction","volume":"174","author":"Daiber","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib29","doi-asserted-by":"crossref","first-page":"34","DOI":"10.5494\/wjh.v2.i4.34","article-title":"Oxidative stress-mediated effects of angiotensin II in the cardiovascular system","volume":"2","author":"Wen","year":"2012","journal-title":"World J. Hypertens."},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.atherosclerosis.2011.02.044","article-title":"Angiotensin converting enzyme inhibitors effect on endothelial dysfunction: a meta-analysis of randomised controlled trials","volume":"216","author":"Shahin","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib31","article-title":"Angiotensin II receptor blockers improve peripheral endothelial function: a meta-analysis of randomized controlled trials","volume":"9","author":"Li","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib32","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0002-9440(10)64523-3","article-title":"Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy","volume":"157","author":"Muller","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib33","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.4049\/jimmunol.1900579","article-title":"A dynamic variation of pulmonary ACE2 is required to modulate neutrophilic inflammation in response to Pseudomonas aeruginosa lung infection in mice","volume":"203","author":"Sodhi","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib34","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1152\/physrev.00023.2016","article-title":"The ACE2\/angiotensin-(1-7)\/MAS Axis of the renin-angiotensin system: focus on angiotensin-(1-7)","volume":"98","author":"Santos","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib35","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejim.2020.04.037","article-title":"The pivotal link between ACE2 deficiency and SARS-CoV-2 infection","volume":"76","author":"Verdecchia","year":"2020","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib36","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1056\/NEJMoa2008975","article-title":"Renin-angiotensin-Aldosterone system inhibitors and risk of covid-19","volume":"382","author":"Reynolds","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib37","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/jama.2020.11301","article-title":"Association of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with COVID-19 diagnosis and mortality","volume":"324","author":"Fosbol","year":"2020","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib38","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1136\/heartjnl-2020-317336","article-title":"Treatment with ACE inhibitors or ARBs and risk of severe\/lethal COVID-19: a meta-analysis","volume":"106","author":"Flacco","year":"2020","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib39","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jamda.2020.06.018","article-title":"The effects of ARBs, ACEis, and statins on clinical outcomes of COVID-19 infection among nursing home residents","volume":"21","author":"De Spiegeleer","year":"2020","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib40","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0140-6736(20)31030-8","article-title":"Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study","volume":"395","author":"de Abajo","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib41","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1093\/eurheartj\/ehaa433","article-title":"Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study","volume":"41","author":"Gao","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib42","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1136\/heartjnl-2020-317393","article-title":"Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people","volume":"106","author":"Hippisley-Cox","year":"2020","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib43","author":"Lopes"},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib44","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1177\/1741826711398430","article-title":"Effects of statins on coronary and peripheral endothelial function in humans: a systematic review and meta-analysis of randomized controlled trials","volume":"18","author":"Reriani","year":"2011","journal-title":"Eur. J. Cardiovasc. Prev. Rehabil."},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib45","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0735-1097(00)01180-3","article-title":"Improvement of coronary artery endothelial dysfunction with lipid-lowering therapy: heterogeneity of segmental response and correlation with plasma-oxidized low density lipoprotein","volume":"37","author":"Penny","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib46","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1089\/ars.2013.5430","article-title":"Statins as regulators of redox state in the vascular endothelium: beyond lipid lowering","volume":"20","author":"Margaritis","year":"2014","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib47","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jacc.2007.10.009","article-title":"Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopathy","volume":"51","author":"Ramasubbu","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib48","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1161\/01.CIR.0000015465.73933.3B","article-title":"Statin prevents tissue factor expression in human endothelial cells: role of Rho\/Rho-kinase and Akt pathways","volume":"105","author":"Eto","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib49","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jacc.2004.11.006","article-title":"Simvastatin improves endothelial function in patients with rheumatoid arthritis","volume":"45","author":"Hermann","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib50","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1086\/505116","article-title":"Pandemic influenza: a potential role for statins in treatment and prophylaxis","volume":"43","author":"Fedson","year":"2006","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2020.10.014_bib51","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cmet.2020.06.015","article-title":"In-hospital use of statins is associated with a reduced risk of mortality among individuals with COVID-19","volume":"32","author":"Zhang","year":"2020","journal-title":"Cell Metabol."},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib52","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1161\/01.CIR.0000037521.71373.44","article-title":"Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis","volume":"106","author":"Hurlimann","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib53","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.trsl.2016.12.003","article-title":"Tocilizumab improves the proatherothrombotic profile of rheumatoid arthritis patients modulating endothelial dysfunction","volume":"183","author":"Ruiz-Limon","year":"2017","journal-title":"NETosis, and inflammation, Transl Res"},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib54","doi-asserted-by":"crossref","first-page":"962S","DOI":"10.1093\/jn\/127.5.962S","article-title":"Oxidants and antioxidants in viral diseases: disease mechanisms and metabolic regulation","volume":"127","author":"Peterhans","year":"1997","journal-title":"J. Nutr."},{"key":"10.1016\/j.atherosclerosis.2020.10.014_bib55","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1093\/eurheartj\/ehr448","article-title":"Cardiovascular effects of flavanol-rich chocolate in patients with heart failure","volume":"33","author":"Flammer","year":"2012","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2020.10.014_bib56","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2014","journal-title":"J. Pathol."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2020.10.014_bib57","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","article-title":"Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2","volume":"181","author":"Monteil","year":"2020","journal-title":"Cell"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915020305815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915020305815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:43:52Z","timestamp":1758156232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915020305815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":57,"alternative-id":["S0021915020305815"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2020.10.014","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endothelial dysfunction in COVID-19: Current findings and therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2020.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}